Effectiveness and Safety of Vedolizumab in Inflammatory Bowel Disease: A Comprehensive Meta-analysis of Observational Studies

被引：0
|
作者：
Macaluso, F. S. [1 ]
Ventimiglia, M. [2 ]
Orlando, A. [1 ]
机构：
[1] Villa Sofia Cervello Hosp, IBD Unit, Palermo, Italy
[2] Italian Minist Hlth, Directorate Gen Med Device & Pharmaceut Serv, Rome, Italy
来源：
JOURNAL OF CROHNS & COLITIS | 2023年 / 17卷
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
P727
引用
收藏
页码：857 / 858
页数：2
相关论文
共 50 条
  • [31] Comparative efficacy and safety of infliximab and vedolizumab therapy in patients with inflammatory bowel disease: a systematic review and meta-analysis
    Peyrin-Biroulet, Laurent
    Arkkila, Perttu
    Armuzzi, Alessandro
    Danese, Silvio
    Guardiola, Jordi
    Jahnsen, Jorgen
    Lees, Charles
    Louis, Edouard
    Lukas, Milan
    Reinisch, Walter
    Roblin, Xavier
    Jang, Minyoung
    Byun, Han Geul
    Kim, Dong-Hyeon
    Lee, Sung Jeong
    Atreya, Raja
    BMC GASTROENTEROLOGY, 2022, 22 (01)
  • [32] Comparative efficacy and safety of infliximab and vedolizumab therapy in patients with inflammatory bowel disease: a systematic review and meta-analysis
    Laurent Peyrin-Biroulet
    Perttu Arkkila
    Alessandro Armuzzi
    Silvio Danese
    Jordi Guardiola
    Jørgen Jahnsen
    Charles Lees
    Edouard Louis
    Milan Lukáš
    Walter Reinisch
    Xavier Roblin
    Minyoung Jang
    Han Geul Byun
    Dong-Hyeon Kim
    Sung Jeong Lee
    Raja Atreya
    BMC Gastroenterology, 22
  • [33] Meta-analysis of the effectiveness and safety of vedolizumab for ulcerative colitis
    Yu Jin
    Yan Lin
    Lian-Jie Lin
    Chang-Qing Zheng
    World Journal of Gastroenterology, 2015, (20) : 6352 - 6360
  • [34] EFFECTIVENESS AND SAFETY OF PEGVISOMANT: META-ANALYSIS OF OBSERVATIONAL LONGITUDINAL STUDIES
    Leonart, L. P.
    Tonin, F. S.
    Ferreira, V. L.
    Fernandez-Llimos, F.
    Pontarolo, R.
    VALUE IN HEALTH, 2018, 21 : S436 - S436
  • [35] Effectiveness and safety of vedolizumab in inflammatory bowel disease patients aged 60 and over: an observational multicenter UK experience
    Ibraheim, Hajir
    Samaan, Mark A.
    Srinivasan, Ashish
    Brain, Oliver
    Digby-Bell, Jonathan
    Irving, Peter M.
    Norman, Irena
    Jawad, Issrah
    Biedermann, Julia
    Ibarra, Ana
    Kok, Klaartje Bel
    Parkes, Gareth
    Rimmer, Joanna
    Compot, Elisabeta
    Parkes, Miles
    Segal, Jonathan
    Oppong, Philip
    Hart, Ailsa
    Hayee, Bu'Hussain
    Powell, Nick
    ANNALS OF GASTROENTEROLOGY, 2020, 33 (02): : 170 - +
  • [36] Effectiveness and safety of acupuncture therapy for inflammatory bowel disease: a protocol of systematic review and meta-analysis
    Zhou, Yuan-Fang
    Sun, Ning
    Cheng, Shi-Rui
    Deng, Xiao-Dong
    Ye, Xiang-Yin
    Li, Zheng-Jie
    Zhou, Jun
    Xu, Gui-Xing
    Qu, Yu-Zhu
    Huang, Liu-Yang
    Sun, Rui-Rui
    Liang, Fan-Rong
    BMJ OPEN, 2021, 11 (08):
  • [37] Inflammatory bowel disease and risk of gastric, small bowel and colorectal cancer: a meta-analysis of 26 observational studies
    Wan, Qianyi
    Zhao, Rui
    Xia, Lin
    Wu, Yutao
    Zhou, Yong
    Wang, Yong
    Cui, Yaping
    Shen, Xiaoding
    Wu, Xiao-Ting
    JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY, 2021, 147 (04) : 1077 - 1087
  • [38] Inflammatory bowel disease and risk of gastric, small bowel and colorectal cancer: a meta-analysis of 26 observational studies
    Qianyi Wan
    Rui Zhao
    Lin Xia
    Yutao Wu
    Yong Zhou
    Yong Wang
    Yaping Cui
    Xiaoding Shen
    Xiao-Ting Wu
    Journal of Cancer Research and Clinical Oncology, 2021, 147 : 1077 - 1087
  • [39] Efficacy and safety of vedolizumab in the treatment of patients with inflammatory bowel disease: A systematic review and meta-analysis of randomized controlled trials
    Tang, Hui-Jun
    Bie, Cai-Qun
    Guo, Li-Liangzi
    Zhong, Li-Xian
    Tang, Shao-Hui
    EXPERIMENTAL AND THERAPEUTIC MEDICINE, 2023, 25 (06)
  • [40] Real-world Effectiveness and Safety of Vedolizumab for the Treatment of Inflammatory Bowel Disease: The Scottish Vedolizumab Cohort
    Plevris, N.
    Chuah, C. S.
    Allen, R. M.
    Arnott, I. D.
    Brennan, P. N.
    Chaudhary, S.
    Churchhouse, A. M. D.
    Din, S.
    Donoghue, E.
    Gaya, D. R.
    Groome, M.
    Jafferbhoy, H. M.
    Jenkinson, P. W.
    Lam, W. L.
    Lyons, M.
    Macdonald, J. C.
    MacMaster, M.
    Mowat, C.
    Naismith, G. D.
    Potts, L. F.
    Saffouri, E.
    Seenan, J. P.
    Sengupta, A.
    Shasi, P.
    Sutherland, D. I.
    Todd, J. A.
    Veryan, J.
    Watson, A. J. M.
    Watts, D. A.
    Jones, G. R.
    Lees, C. W.
    JOURNAL OF CROHNS & COLITIS, 2019, 13 (09): : 1111 - 1120
12345